دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Reducing use of triple therapy after percutaneous coronary intervention: Results from a hospital-wide quality improvement initiative
William Earle MD, George Abdallah PharmD, Sean Meagher MD, Kaden Shen BS, C. Michael Gibson MD, Kalon K. L. Ho MD, MSc, Eric A. Secemsky MD, MSc
doi : 10.1002/ccd.30412
Trials have shown that for patients on oral anticoagulants (OAC), a short course of dual antiplatelet therapy (DAPT) with OAC reduces post-percutaneous coronary intervention (PCI) bleeding without increasing ischemic events. Adoption of this strategy has been variable. We evaluated the impact of an institutional quality improvement (QI) initiative to reduce the use of triple therapy (TT, OAC + DAPT) and improve discharge communication post-PCI.
Driving quality improvement with nudges: True interventions in cardiology
Arnold H. Seto MD, MPA
doi : 10.1002/ccd.30475
Initial experience with a continuous mechanical aspiration system for thrombus removal before percutaneous coronary intervention
S. Jay Mathews MD, MS, Christopher L. Brown MD, Brian C. Kolski MD, Vasco M. Marques MD, Andrew Huynh MD, Suhail Y. Dohad MD, Jon C. George MD
doi : 10.1002/ccd.30389
Here we investigate the safety and efficacy of a continuous mechanical aspiration system when used before percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS).
Impact of intracoronary assessments on revascularization decisions: A contemporary evaluation
Taylor Gillmore MSc, Richard G. Jung MD, PhD, Robert Moreland MD, Pietro Di Santo MD, Cameron Stotts BSc, Dwipen Makwana BSc, Omar Abdel-Razek MD, Zeeshan Ahmed MD, Kevin Chung MD, Simon Parlow MD, Trevor Simard MD, Michael Froeschl MD, Marino Labinaz MD, Benjamin Hibbert MD, PhD
doi : 10.1002/ccd.30417
To investigate the real-world implementation of intracoronary assessment (ICA) techniques and evaluate their impact on clinical decisions regarding the management of coronary artery disease (CAD) in contemporary practice.
Diagnostic accuracy of angiography-based vessel fractional flow reserve after chronic coronary total occlusion recanalization
Alessandra Scoccia MD, Paola Scarparo MD, Tara Neleman BSc, Hala Kakar MD, Jeroen Wilschut MD, Wijnand K. Den Dekker MD, PhD, Felix Zijlstra MD, PhD, Nicolas M. Van Mieghem MD, PhD, Joost Daemen MD, PhD, Roberto Diletti MD, PhD
doi : 10.1002/ccd.30439
Angiography-based vessel fractional flow reserve (vFFR) demonstrated a strong correlation with invasive fractional flow reserve (FFR) in both a pre- and post-percutaneous coronary intervention (PCI) setting. However, the role of vFFR and its correlation with post-PCI FFR in chronic coronary occlusions (CTO) has not been evaluated yet. We sought to investigate the diagnostic performance of post-PCI vFFR with post-PCI FFR as a reference in patients undergoing successful CTO PCI.
Long-term outcomes of intermediate coronary stenosis in patients undergoing hemodialysis after deferred revascularization based on fractional flow reserve
Takashi Nagasaka MD, PhD, Shiro Amanai MD, Yohei Ishibashi MD, Kazufumi Aihara MD, Yoshiaki Ohyama MD, PhD, Noriaki Takama MD, PhD, Norimichi Koitabashi MD, PhD, Hideki Ishii MD, PhD
doi : 10.1002/ccd.30421
This study aimed to assess the long-term outcomes of patients undergoing hemodialysis (HD) after deferred revascularization based on fractional flow reserve (FFR).
Combined rotational atherectomy and cutting balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions: The PREPARE-CALC-COMBO study
Abdelhakim Allali MD, Ralph Toelg MD, Mohamed Abdel-Wahab MD, Rayyan Hemetsberger MD, Adnan Kastrati MD, Nader Mankerious MD, Hussein Traboulsi MD, Karim Elbasha MD, Tobias Rheude MD, Martin Landt MD, Volker Geist MD, Gert Richardt MD
doi : 10.1002/ccd.30423
To evaluate the safety and efficacy of lesion preparation using rotational atherectomy (RA) with consecutive cutting balloon angioplasty (Rota-Cut).
Outcomes of paclitaxel-coated balloon angioplasty for in-stent calcified nodule: An optical coherence tomography study
Hisaki Masuda MD, Shoichi Kuramitsu MD, PhD, FSCAI, Tomoaki Ito MS, Toru Morofuji MD, Takenori Domei MD, Makoto Hyodo MD, Shinichi Shirai MD, Kenji Ando MD
doi : 10.1002/ccd.30418
Paclitaxel-coated balloon (PCB) angioplasty emerges as an effective therapeutic option for in-stent restenosis (ISR). However, whether PCB angioplasty would be effective for in-stent calcified nodule (ISCN) lesions remain fully understood. This study aimed to evaluate the frequency and outcomes of ISCN in patients undergoing PCB angioplasty for ISR after second-generation drug-eluting stents (G2-DES) implantation.
Impact of intravascular ultrasound-incomplete stent apposition on stent failure
Yusuke Watanabe MD, Kenichi Sakakura MD, Yousuke Taniguchi MD, Kei Yamamoto MD, Masaru Seguchi MD, Takunori Tsukui MD, Hiroyuki Jinnouchi MD, Hiroshi Wada MD, Hideo Fujita MD
doi : 10.1002/ccd.30424
This study aimed to investigate the relationship between immediate incomplete stent apposition (ISA) detected by intravascular ultrasound (IVUS) and midterm stent failure.
Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry
Spyridon Kostantinis MD, Bahadir Simsek MD, Judit Karacsonyi MD, PhD, Khaldoon Alaswad MD, Mir B. Basir DO, Michael Megaly MD, Sevket Gorgulu MD, Oleg Krestyaninov MD, Dmitrii Khelimskii MD, Rhian E. Davies DO, Stewart M. Benton Jr, MD, Jaikirshan J. Khatri MD, Ahmed M. ElGuindy MD, Omer Goktekin MD, Nidal Abi Rafeh MD, Salman Allana MD, Emmanouil S. Brilakis MD, PhD, Megha Prasad MD, MS
doi : 10.1002/ccd.30425
There are limited data describing gender differences in patients undergoing chronic total occlusion (CTO) percutaneous coronary interventions (PCI).
“Does gender equality also apply to chronic total occlusion management?�
Carlo Di Mario MD, PhD, FESC, FACC, FSCAI, FRCP, Francesca Maria Di Muro MD
doi : 10.1002/ccd.30489
Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention
Michael Megaly MD, MS, Kevin Buda DO, Judit Karacsonyi MD, PhD, Spyridon Kostantinis MD, Bahadir Simsek MD, Mir B. Basir DO, Kambis Mashayekhi MD, Stephane Rinfret MD, SM, Margaret McEntegart MD, Masahisa Yamane MD, Lorenzo Azzalini MD, Khaldoon Alaswad MD, Emmanouil S. Brilakis MD, Ph.D.
doi : 10.1002/ccd.30403
To compare the clinical outcomes after extraplaque (EP) versus intraplaque (IP) tracking in chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
Feasibility of facilitated antegrade dissection with Stingray-based re-entry for coronary chronic total occlusions with previously stented graft-to-native-vessel anastomoses
Shane Parfrey MB, BCh, BAO, Abdul Mozid MBBS, BMedSci, MD
doi : 10.1002/ccd.30426
Facilitated antegrade dissection re-entry (F-ADR) is a technique described for treating post coronary artery bypass surgery chronic total occlusions (CTO) when there is flush occlusion of the distal cap of the CTO at the vein graft anastomosis. In this scenario retrograde access is usually impossible and if antegrade wiring fails, F-ADR is then the best option.
Lithotripsy for calcified in-stent restenosis. The “rock strata peeling pattern�: A novel fracture pattern detected by optical coherence tomography
David del Val MD, Javier Cuesta MD, PhD, Pilar Roquero MD, Fernando Alfonso MD, PhD
doi : 10.1002/ccd.30420
Calcified neoatherosclerosis represents a particularly challenging scenario in patients with in-stent restenosis (ISR), frequently associated with worse angiographic and optical coherence tomography (OCT) results compared with other patients with typical ISR.
Single-access for Impella-supported percutaneous coronary intervention using a sheathless technique with an 8 Fr guide
Louis Verreault-Julien MD, MPH, Nikoloz Shekiladze MD, Jason Wollmuth MD, Stéphane Rinfret MD, SM, FRCP(C), FSCAI
doi : 10.1002/ccd.30427
Complex and higher-risk indicated percutaneous coronary interventions at times require mechanical circulatory support, most often with Impella devices. The use of such devices traditionally required additional arterial access site(s), increasing risk of vascular complications.
Single-access technique for Impella-assisted PCI: How to take hold of Impella by the smooth handle
Giuseppe Tarantini MD, PhD, FESC, Tommaso Fabris MD
doi : 10.1002/ccd.30477
Is FFR dead? A conversation in cardiology
Morton J. Kern MD, David Cox MD, William Fearon MD, Nils Johnson MD, Lloyd Klein MD, Mitch Krucoff MD, Jeffery Moses MD, Srihari S. Naidu MD, Duane Pinto MD, Steve Ramee MD, Paul Teirstein MD, Alan Yeung MD
doi : 10.1002/ccd.30422
The bioresorbable magnesium scaffold (Magmaris)�State of the art: From basic concept to clinical application
Piotr Rola MD, PhD, Szymon WÅ‚odarczak MD, Adrian Doroszko, Maciej Lesiak, Adrian WÅ‚odarczak MD, PhD
doi : 10.1002/ccd.30435
Since its introduction to clinical practice, coronary artery stent implantation has become a crucial part of the therapy of coronary artery disease (CAD). Despite the undeniable evolution of percutaneous coronary revascularization procedures, drug-eluting stent (DES) technology shows some limitations.
Stent expansion of restrictive Fontan conduits to nominal diameter and beyond
Thomas Salaets, Bjorn Cools PhD, Pieter De Meester, Ruth Heying PhD, Derize Boshoff PhD, Benedicte Eyskens PhD, Stephen Brown DMeD, Bart Meyns PhD, Filip Rega PhD, Joeri Van Puyvelde, Werner Budts PhD, Marc Gewillig MD, PhD
doi : 10.1002/ccd.30438
Mechanical factors may cause bottlenecks in a Fontan circuit. Extracardiac conduits (ECC) are placed at a young age, but the materials do not allow growth. Restriction in ECC dimensions may deteriorate the function of the circuit.
Novel technique for transcatheter closure of sinus venosus atrial septal defect: The temporary suture-holding technique
Yahia Hejazi MD, Ziyad M. Hijazi MD, PhD, Hesham Al Saloos MD, Haytham Ibrahim MD, Gurdeep S. Mann MD, Younes Boudjemline MD, PhD
doi : 10.1002/ccd.30415
Transcatheter repair of sinus venosus atrial septal defect (SVASD) has become an alternative option to surgical repair. There are potential significant complications related to stent stability in the superior vena cava (SVC) and potential migration of the stent that need to be addressed. Therefore, the technique is still evolving.
Evaluation of safety and efficacy of the S.M.A.R.T.® Flex Vascular Stent System (OPEN study)
William A. Gray MD, FSCAI, Joseph Cardenas MD, Corey L. Teigen MD
doi : 10.1002/ccd.30414
The OPEN study evaluated the safety and efficacy of the S.M.A.R.T.® Flex Vascular Stent System in patients with femoropopliteal arterial disease.
“The Hunterian approach: Cordis Smart Stent safe and effective, but what about its use in long or severely calcified chronically occluded lesions… Let's get it done the first time�
Richard R. Heuser MD, FACP, FESC, MSCAI
doi : 10.1002/ccd.30501
PERFORMANCE 1 study: Novel carotid stent system with integrated post-dilation balloon and embolic protection device
Ralf Langhoff MD, Ivo Petrov MD, PhD, Sasko Kedev MD, PhD, Zoran Milosevic MD, Andrej Schmidt MD, Dierk Scheinert MD, PhD, Joachim Schofer MD, PhD, Horst Sievert MD, PhD, Gerald Sedgewick BA, Elizabeth Saylors MSc, Ravish Sachar MD, Alberto Cremonesi MD, PhD, Antonio Micari MD
doi : 10.1002/ccd.30410
The PERFORMANCE I study was designed to evaluate the safety and feasibility of the Neuroguard IEP® System, a novel carotid stent system with an integrated embolic filter and post-dilatation balloon, to treat clinically significant carotid artery stenosis.
Twelve-month safety and effectiveness of TCD-17187 drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery
Osamu Iida MD, PhD, Yoshimitsu Soga MD, PhD, Shu-Ichi Seki MD, Daizo Kawasaki MD, PhD, Hitoshi Anzai MD, Hiroshi Ando MD, PhD, Tatsuya Nakama MD, Norihiko Shinozaki MD, PhD, Amane Kozuki MD, PhD, Masaharu Ishihara MD, PhD, Kazushi Urasawa MD, PhD, Satoru Toi MD, Hiroaki Tsujita MD, PhD, Kazuki Tobita MD, Kenji Ogata MD, Kazunori Horie MD, Naoki Hayakawa MD, Shinsuke Mori MD, Masahiko Fujihara MD, Takao Ohki MD, PhD, Kenichiro Yuba MD, Toshiaki Mano MD, PhD, Masato Nakamura MD, PhD, TCD-17187 Japan Investigators
doi : 10.1002/ccd.30408
The aim of this preapproval trial was to evaluate the 12-month safety and effectiveness of the TCD-17187 drug-coated balloon (DCB) for the treatment of atherosclerotic lesions in the superficial femoral artery (SFA) and/or proximal popliteal artery (PA).
Trends in invasive treatment of patients hospitalized with aortic stenosis complicated by cardiogenic shock
Ahmed Elkaryoni MD, David J. Cohen MD, MSc, John J. Lopez MD, Chetan P. Huded MD, MSc, Kevin F. Kennedy MS, Suzanne V. Arnold MD, MHA
doi : 10.1002/ccd.30413
Before the development of transcatheter aortic valve replacement (TAVR), balloon aortic valvuloplasty (BAV) was the only potential nonsurgical intervention for patients with aortic stenosis complicated by cardiogenic shock. Emergent TAVR is now an option and has shown acceptable outcomes compared with elective TAVR. We explored how treatment patterns for aortic stenosis and cardiogenic shock among patients received invasive intervention have shifted since TAVR was introduced.
Intervention for aortic stenosis complicated by shock: Focus on the ventricle
David G. Rizik MD, MSCAI, James A. Goldstein MD
doi : 10.1002/ccd.30486
Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database
Waqas Ullah MD, Salman Zahid MD, Hamza Muhammadzai MD, Fouad Khalil MD, Arnav Kumar MD, Abdul Mannan Khan Minhas MD, Muhammad Zia Khan MD, Salim S. Virani MD, FACC, David L. Fischman MD, FACC, Pinak Shah MD, Deepak L. Bhatt MD, MPH, FACC, FAHA, MSCAI, FESC
doi : 10.1002/ccd.30407
Transcatheter aortic valve implantation (TAVI) has increasingly been utilized in patients with bicuspid aortic valve (BAV) related aortic stenosis (AS) with insufficient large-scale data on its safety.
Data are data: Do we need a randomized trial of transcatheter aortic valve replacement for bicuspid valves?
Hiroki Ueyama MD, Peter C. Block MD, FACC, MSCAI
doi : 10.1002/ccd.30479
Non-surgical extirpation of a non-infectious expanding tricuspid valve mass by percutaneous aspiration thrombectomy
Blerina Asllanaj MD, Alexander Urzua MD, Anthony Dota MD, Jeffrey Levisman MD
doi : 10.1002/ccd.30428
Marantic endocarditis refers to a noninfectious lesion, usually in the aortic and mitral valves, that is most commonly seen in advanced malignancy and systemic lupus erythematosus. Inflammatory conditions, including antiphospholipid syndrome (APS), are a rare etiology making up less than 20% of reported cases. The condition is thought to be due to a hypercoagulable state and found postmortem with rates in autopsy series ranging from 0.9% to 1.6%.
Erratum to “Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience�
doi : 10.1002/ccd.30409
Why complex and high risk percutaneous coronary interventions should be offered to selected octogenarians/nonagenarians
Salman S. Allana MD, Emmanouil S. Brilakis MD, PhD
doi : 10.1002/ccd.30474
Peripheral arterial disease and multisite atherosclerosis in patients undergoing percutaneous coronary intervention
Raffaele Piccolo MD, PhD, Giovanni Esposito MD, PhD
doi : 10.1002/ccd.30478
Percutaneous Coronary Intervention of bifurcation lesions: The proof is in the pudding!
Ashok Seth FRCP, MSCAI, DSc, Babu Ezhumalai MD, DM, FNB, FACC, FESC, FAPSIC, FSCAI
doi : 10.1002/ccd.30493
